Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00169065Phase 4Completed
A Phase 4 trial of olanzapine in schizophrenia, sponsored by Harvard Medical School. Started Aug 1998; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00169065.